Teva's opioid settlement moves forward with participation from 48 states
Teva Pharmaceuticals only has two more states to go before the entire nation has either reached settlements or agreed to participate in a settlement deal with the generics giant over its role in the US opioid epidemic, the company announced today.
With 48 states under its belt, Teva said it’s at “a sufficient level” to move forward with its nationwide settlement agreement to resolve opioid-related claims. Teva will still continue to pursue the two holdout states, New Mexico and Nevada, in a bid to get them to participate, the company told Endpoints News via email.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
